94 related articles for article (PubMed ID: 11510493)
1. Apparent low frequency of sequence variability within the proximal promoter region of the cytochrome P450 (CYP) 3A5 gene in established cell lines from Japanese individuals.
Nakamura T; Saito Y; Murayama N; Saeki M; Soyama A; Sai K; Ozawa S; Sawada J
Biol Pharm Bull; 2001 Aug; 24(8):954-7. PubMed ID: 11510493
[TBL] [Abstract][Full Text] [Related]
2. Genotyping cytochrome P450 3A5 using the Light Cycler.
Fredericks S; Moreton M; MacPhee IA; Mohamed M; Marlowe S; Jorga A; Johnston A; Carter ND; Holt DW
Ann Clin Biochem; 2005 Sep; 42(Pt 5):376-81. PubMed ID: 16168193
[TBL] [Abstract][Full Text] [Related]
3. Frequencies of CYP3A5 genotypes and haplotypes in a Korean population.
Park SY; Kang YS; Jeong MS; Yoon HK; Han KO
J Clin Pharm Ther; 2008 Feb; 33(1):61-5. PubMed ID: 18211618
[TBL] [Abstract][Full Text] [Related]
4. Multiplex PCR-pyrosequencing assay for genotyping CYP3A5 polymorphisms.
Aquilante CL; Langaee TY; Anderson PL; Zineh I; Fletcher CV
Clin Chim Acta; 2006 Oct; 372(1-2):195-8. PubMed ID: 16701601
[TBL] [Abstract][Full Text] [Related]
5. Novel detection assay by PCR-RFLP and frequency of the CYP3A5 SNPs, CYP3A5*3 and *6, in a Japanese population.
Fukuen S; Fukuda T; Maune H; Ikenaga Y; Yamamoto I; Inaba T; Azuma J
Pharmacogenetics; 2002 Jun; 12(4):331-4. PubMed ID: 12042671
[TBL] [Abstract][Full Text] [Related]
6. Identification by single-strand conformational polymorphism analysis of known and new mutations of the CYP3A5 gene in a French population.
Quaranta S; Chevalier D; Bourgarel-Rey V; Allorge D; Solas C; Lo-Guidice JM; Sampol-Manos E; Vacher-Coponat H; Moal V; Broly F; Lhermitte M; Lacarelle B
Toxicol Lett; 2006 Jul; 164(2):177-84. PubMed ID: 16442753
[TBL] [Abstract][Full Text] [Related]
7. Sequence diversity in CYP3A promoters and characterization of the genetic basis of polymorphic CYP3A5 expression.
Kuehl P; Zhang J; Lin Y; Lamba J; Assem M; Schuetz J; Watkins PB; Daly A; Wrighton SA; Hall SD; Maurel P; Relling M; Brimer C; Yasuda K; Venkataramanan R; Strom S; Thummel K; Boguski MS; Schuetz E
Nat Genet; 2001 Apr; 27(4):383-91. PubMed ID: 11279519
[TBL] [Abstract][Full Text] [Related]
8. Identification of a novel dexamethasone responsive enhancer in the human CYP3A5 gene and its activation in human and rat liver cells.
Schuetz JD; Schuetz EG; Thottassery JV; Guzelian PS; Strom S; Sun D
Mol Pharmacol; 1996 Jan; 49(1):63-72. PubMed ID: 8569713
[TBL] [Abstract][Full Text] [Related]
9. Haplotypes of CYP3A4 and their close linkage with CYP3A5 haplotypes in a Japanese population.
Fukushima-Uesaka H; Saito Y; Watanabe H; Shiseki K; Saeki M; Nakamura T; Kurose K; Sai K; Komamura K; Ueno K; Kamakura S; Kitakaze M; Hanai S; Nakajima T; Matsumoto K; Saito H; Goto Y; Kimura H; Katoh M; Sugai K; Minami N; Shirao K; Tamura T; Yamamoto N; Minami H; Ohtsu A; Yoshida T; Saijo N; Kitamura Y; Kamatani N; Ozawa S; Sawada J
Hum Mutat; 2004 Jan; 23(1):100. PubMed ID: 14695543
[TBL] [Abstract][Full Text] [Related]
10. Single nucleotide polymorphisms and haplotype frequencies of CYP3A5 in a Japanese population.
Saeki M; Saito Y; Nakamura T; Murayama N; Kim SR; Ozawa S; Komamura K; Ueno K; Kamakura S; Nakajima T; Saito H; Kitamura Y; Kamatani N; Sawada J
Hum Mutat; 2003 Jun; 21(6):653. PubMed ID: 14961555
[TBL] [Abstract][Full Text] [Related]
11. Impact of cytochrome p450 3A5 genetic polymorphism on tacrolimus doses and concentration-to-dose ratio in renal transplant recipients.
Thervet E; Anglicheau D; King B; Schlageter MH; Cassinat B; Beaune P; Legendre C; Daly AK
Transplantation; 2003 Oct; 76(8):1233-5. PubMed ID: 14578760
[TBL] [Abstract][Full Text] [Related]
12. CYP3A5*3 and CYP3A4*18 single nucleotide polymorphisms in a Chinese population.
Hu YF; He J; Chen GL; Wang D; Liu ZQ; Zhang C; Duan LF; Zhou HH
Clin Chim Acta; 2005 Mar; 353(1-2):187-92. PubMed ID: 15698606
[TBL] [Abstract][Full Text] [Related]
13. Genotype-phenotype associations of cytochrome P450 3A4 and 3A5 polymorphism with midazolam clearance in vivo.
He P; Court MH; Greenblatt DJ; Von Moltke LL
Clin Pharmacol Ther; 2005 May; 77(5):373-87. PubMed ID: 15900284
[TBL] [Abstract][Full Text] [Related]
14. Cytochrome P450 3A-dependent metabolism of a potent and selective gamma-aminobutyric acid Aalpha2/3 receptor agonist in vitro: involvement of cytochrome P450 3A5 displaying biphasic kinetics.
Ma B; Polsky-Fisher SL; Vickers S; Cui D; Rodrigues AD
Drug Metab Dispos; 2007 Aug; 35(8):1301-7. PubMed ID: 17460031
[TBL] [Abstract][Full Text] [Related]
15. The genetic determinants of the CYP3A5 polymorphism.
Hustert E; Haberl M; Burk O; Wolbold R; He YQ; Klein K; Nuessler AC; Neuhaus P; Klattig J; Eiselt R; Koch I; Zibat A; Brockmöller J; Halpert JR; Zanger UM; Wojnowski L
Pharmacogenetics; 2001 Dec; 11(9):773-9. PubMed ID: 11740341
[TBL] [Abstract][Full Text] [Related]
16. Variation in oral clearance of saquinavir is predicted by CYP3A5*1 genotype but not by enterocyte content of cytochrome P450 3A5.
Mouly SJ; Matheny C; Paine MF; Smith G; Lamba J; Lamba V; Pusek SN; Schuetz EG; Stewart PW; Watkins PB
Clin Pharmacol Ther; 2005 Dec; 78(6):605-18. PubMed ID: 16338276
[TBL] [Abstract][Full Text] [Related]
17. Transcription factor binding to a putative double E-box motif represses CYP3A4 expression in human lung cells.
Biggs JS; Wan J; Cutler NS; Hakkola J; Uusimäki P; Raunio H; Yost GS
Mol Pharmacol; 2007 Sep; 72(3):514-25. PubMed ID: 17548528
[TBL] [Abstract][Full Text] [Related]
18. Genetic findings and functional studies of human CYP3A5 single nucleotide polymorphisms in different ethnic groups.
Lee SJ; Usmani KA; Chanas B; Ghanayem B; Xi T; Hodgson E; Mohrenweiser HW; Goldstein JA
Pharmacogenetics; 2003 Aug; 13(8):461-72. PubMed ID: 12893984
[TBL] [Abstract][Full Text] [Related]
19. CYP3A variation and the evolution of salt-sensitivity variants.
Thompson EE; Kuttab-Boulos H; Witonsky D; Yang L; Roe BA; Di Rienzo A
Am J Hum Genet; 2004 Dec; 75(6):1059-69. PubMed ID: 15492926
[TBL] [Abstract][Full Text] [Related]
20. CYP3A5 genetic polymorphisms in different ethnic populations.
Roy JN; Lajoie J; Zijenah LS; Barama A; Poirier C; Ward BJ; Roger M
Drug Metab Dispos; 2005 Jul; 33(7):884-7. PubMed ID: 15833928
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
